Bulletin
Investor Alert

Jan. 16, 2022, 4:14 a.m. EST

Ishares Biotechnology Etf IBB Investment Advice

Jan 16, 2022 (Stock Traders Daily via COMTEX) -- Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in Ishares Biotechnology Etf (NAS:IBB) with integrated risk controls.

The trading plans were valid at the time this was published, but the support and resistance levels for IBB change as time passes, and this should be updated in real time. Access those real time updates for this and 1000 other stocks here. Unlimited Real Time Reports

Protection from Market Crashes: Subscribers also get our Tail Risk hedge, Evitar Corte

Use the basic rules of Technical Analysis. Here are some examples: if IBB is testing support the signal is to buy and target resistance. On the other hand, if resistance is tested, that is a sign to short, and target support. No matter which side the trade is, long or short, the trigger point is both a place to enter and as a risk control.

This data can be used to define Day Trading, Swing Trading, and Long Term Investing plans for IBB too. All of these are offered here: Access our Real Time Trading Plans

  • NONE.

  • Short IBB under 149.99, target n/a, stop loss @ 150.42

  • Buy IBB over 141.30, target 149.99, Stop Loss @ 140.89

  • Short IBB near 141.30, target 135.68, Stop Loss @ 141.71.

  • Buy IBB over 140.11, target 141.30, Stop Loss @ 139.78

  • Short IBB near 140.11, target 135.68, Stop Loss @ 140.44.

IBB Technical Summary | Raw Data for the Trading Plans

Bias Weak Neutral Neutral
P1 0 0 149.99
P2 140.11 135.68 160.42
P3 143.10 141.30 170.45

COMTEX_400622690/2570/2022-01-16T04:13:51

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Link to MarketWatch's Slice.